Original price was: $95.00.$78.00Current price is: $78.00.
32 in stock
| Peptide | Sequence / Details | CAS No. |
|---|---|---|
| BPC‑157 | Pentadecapeptide (15 amino acids) derived from gastric juice protein BPC; sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | 137525-51-0 (experimental) |
| TB‑500 | Synthetic peptide fragment of Thymosin Beta‑4, sequence: Ac‑Ser-Asp-Lys-Pro-Val-Lys‑Thr‑Thr‑Lys‑Pro‑Glu‑Lys‑Thr‑Glu‑Lys‑Lys‑Val‑Lys‑Glu‑Lys‑Pro‑Asp‑Lys | 77591-33-4 (experimental) |
BPC‑157:
Promotes angiogenesis, tissue repair, and cytoprotection.
Supports healing of muscle, tendon, ligament, and gastrointestinal tract injuries.
Shown to modulate nitric oxide pathways and inflammatory cytokines in rodent models.
TB‑500:
Mimics thymosin beta‑4, enhances actin polymerization and cell migration.
Facilitates wound healing, reduces inflammation, and promotes tissue regeneration in muscles, tendons, and skin.
Both peptides are traditionally researched via injection (subcutaneous or intramuscular).
Oral forms are experimental; bioavailability and pharmacokinetics in humans are poorly characterized.
Stability in the GI tract may be limited due to enzymatic degradation; enteric coatings and other delivery tech are under investigation.
Research into oral delivery is ongoing but no FDA-approved oral formulations exist.
Store lyophilized powder at –20 °C in a dry environment, protect from light.
Reconstitute with sterile water or saline just prior to use; oral solutions may require stabilizers (research-dependent).
Use aseptic technique for handling.
Dispose of all materials per institutional biohazard waste policies.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.